• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子和白细胞介素-1是血管紧张素II诱导的醛固酮合成的有效抑制剂。

Tumor necrosis factor and interleukin-1 are potent inhibitors of angiotensin-II-induced aldosterone synthesis.

作者信息

Natarajan R, Ploszaj S, Horton R, Nadler J

机构信息

Section of Endocrinology, University of Southern California, Los Angeles County Medical Center 90033.

出版信息

Endocrinology. 1989 Dec;125(6):3084-9. doi: 10.1210/endo-125-6-3084.

DOI:10.1210/endo-125-6-3084
PMID:2555138
Abstract

Cytokines such as tumor necrosis factor (TNF) and interleukin-1 (IL-1), mediate many inflammatory and cellular responses. However, the effects of TNF and IL-1 on basal and angiotensin-II (AII)-stimulated aldosterone synthesis are not known. We studied the effect of recombinant and purified TNF and IL-1 on basal as well as AII-, ACTH-, and K+-induced aldosterone synthesis in isolated rat adrenal glomerulosa cells. Since we have previously shown that AII action is mediated by activation of the 12-lipoxygenase (12LO) pathway of arachidonic acid, we also evaluated the effects of these cytokines on the 12LO product 12-hydroxyeicosatetraenoic acid (12HETE) using a validated RIA technique. TNF at 2.5 and 5.0 ng/ml produced a dose-dependent inhibition of AII-induced aldosterone synthesis [AII, 39.0 +/- 3.3 ng/10(6) cells.h; AII plus TNF (5.0 ng/ml), 14.3 +/- 1.6; P less than 0.001 vs. AII; AII plus TNF (2.5 ng/ml), 24.7 +/- 3.2; P less than 0.01 vs. AII]. Similarly, TNF at 5.0 ng/ml also attenuated the stimulatory effect of ACTH (10(-9) M). However, K+-induced aldosterone synthesis was not altered. TNF also did not alter basal aldosterone levels. AII, as previously shown, stimulates 12HETE synthesis (basal, 608 +/- 114 pg/10(5) cells.h; versus AII, 1268 +/- 197; P less than 0.02). TNF at concentrations of 1.0-5.0 ng/ml produced a dose-dependent inhibition of AII stimulatory action on 12HETE synthesis [AII plus TNF (1.0 ng/ml), 650 +/- 26 pg, P less than 0.03 vs. AII; AII plus TNF (5.0 ng/ml), 390 +/- 46; P less than 0.01 vs. AII plus TNF (1.0 ng/ml)]. In addition, 12HETE at 10(-8) M completely restored the effects of AII during blockage by TNF. Purified human IL-1 (75% beta, 25% alpha) as well as recombinant human IL-1 beta at concentrations as low as 50 pg/ml inhibited AII-induced aldosterone synthesis. IL-1 beta did not alter ACTH- or K+-induced aldosterone synthesis and, in fact, had a tendency to potentiate ACTH effects. These results suggest that the cytokines TNF and IL-1 are potent inhibitors, particularly of AII action in the adrenal glomerulosa cell. Therefore, local or systemically produced TNF or IL-1 may be important negative modulators of aldosterone synthesis.

摘要

细胞因子如肿瘤坏死因子(TNF)和白细胞介素-1(IL-1)介导许多炎症和细胞反应。然而,TNF和IL-1对基础及血管紧张素-II(AII)刺激的醛固酮合成的影响尚不清楚。我们研究了重组和纯化的TNF及IL-1对分离的大鼠肾上腺球状带细胞基础以及AII、促肾上腺皮质激素(ACTH)和钾离子(K⁺)诱导的醛固酮合成的影响。由于我们之前已表明AII的作用是由花生四烯酸的12-脂氧合酶(12LO)途径的激活介导的,我们还使用经过验证的放射免疫分析(RIA)技术评估了这些细胞因子对12LO产物12-羟基二十碳四烯酸(12HETE)的影响。2.5和5.0 ng/ml的TNF对AII诱导的醛固酮合成产生剂量依赖性抑制作用[AII,39.0±3.3 ng/10⁶细胞·小时;AII加TNF(5.0 ng/ml),14.3±1.6;与AII相比,P<0.001;AII加TNF(2.5 ng/ml),24.7±3.2;与AII相比,P<0.01]。同样,5.0 ng/ml的TNF也减弱了ACTH(10⁻⁹M)的刺激作用。然而,K⁺诱导的醛固酮合成未改变。TNF也未改变基础醛固酮水平。如先前所示,AII刺激12HETE合成(基础,608±114 pg/10⁵细胞·小时;与AII相比,1268±197;P<0.02)。1.0 - 5.0 ng/ml浓度的TNF对AII刺激12HETE合成的作用产生剂量依赖性抑制作用[AII加TNF(1.0 ng/ml),650±26 pg,与AII相比,P<0.03;AII加TNF(5.0 ng/ml),390±46;与AII加TNF(1.0 ng/ml)相比,P<0.01]。此外,10⁻⁸M的12HETE在TNF阻断期间完全恢复了AII的作用。纯化的人IL-1(75%β,25%α)以及低至50 pg/ml浓度的重组人IL-1β抑制AII诱导的醛固酮合成。IL-1β未改变ACTH或K⁺诱导的醛固酮合成,实际上,有增强ACTH作用的趋势。这些结果表明细胞因子TNF和IL-1是强效抑制剂,特别是对肾上腺球状带细胞中AII的作用。因此,局部或全身产生的TNF或IL-1可能是醛固酮合成的重要负调节因子。

相似文献

1
Tumor necrosis factor and interleukin-1 are potent inhibitors of angiotensin-II-induced aldosterone synthesis.肿瘤坏死因子和白细胞介素-1是血管紧张素II诱导的醛固酮合成的有效抑制剂。
Endocrinology. 1989 Dec;125(6):3084-9. doi: 10.1210/endo-125-6-3084.
2
Selective inhibition of angiotensin-II-mediated aldosterone secretion by 5-hydroxyeicosatetraenoic acid.5-羟基二十碳四烯酸对血管紧张素-II介导的醛固酮分泌的选择性抑制作用
Endocrinology. 1989 Dec;125(6):3090-5. doi: 10.1210/endo-125-6-3090.
3
Potential role of 12 hydroxyeicosatetraenoic acid in angiotensin II-induced calcium signal in rat glomerulosa cells.12-羟基二十碳四烯酸在血管紧张素II诱导的大鼠肾小球膜细胞钙信号中的潜在作用
Endocrinology. 1993 Aug;133(2):843-7. doi: 10.1210/endo.133.2.8344221.
4
Role of the lipoxygenase pathway in angiotensin II-mediated aldosterone biosynthesis in human adrenal glomerulosa cells.脂氧合酶途径在人肾上腺球状带细胞中血管紧张素II介导的醛固酮生物合成中的作用。
J Clin Endocrinol Metab. 1988 Sep;67(3):584-91. doi: 10.1210/jcem-67-3-584.
5
Specific action of the lipoxygenase pathway in mediating angiotensin II-induced aldosterone synthesis in isolated adrenal glomerulosa cells.脂氧合酶途径在介导血管紧张素II诱导的离体肾上腺球状带细胞醛固酮合成中的特定作用。
J Clin Invest. 1987 Dec;80(6):1763-9. doi: 10.1172/JCI113269.
6
Angiotensin II-induced aldosterone synthesis is potentiated by epidermal growth factor.表皮生长因子可增强血管紧张素 II 诱导的醛固酮合成。
Endocrinology. 1991 May;128(5):2285-90. doi: 10.1210/endo-128-5-2285.
7
Magnesium modulates ouabain action on angiotensin II-induced aldosterone synthesis in vitro.镁在体外调节哇巴因对血管紧张素II诱导的醛固酮合成的作用。
Magnes Res. 1997 Dec;10(4):307-13.
8
Platelet-derived growth factor is a potent inhibitor of angiotensin II-induced aldosterone synthesis.血小板衍生生长因子是血管紧张素 II 诱导的醛固酮合成的有效抑制剂。
Mol Cell Endocrinol. 1992 Jan;83(1):57-63. doi: 10.1016/0303-7207(92)90195-c.
9
Interaction between serotonin and other regulators of aldosterone secretion in rat adrenal glomerulosa cells.大鼠肾上腺球状带细胞中血清素与醛固酮分泌的其他调节因子之间的相互作用。
Endocrinology. 1990 Dec;127(6):3103-10. doi: 10.1210/endo-127-6-3103.
10
Tumor necrosis factor and interleukin-1 may regulate renin secretion.肿瘤坏死因子和白细胞介素-1可能调节肾素分泌。
Endocrinology. 1990 Jan;126(1):273-8. doi: 10.1210/endo-126-1-273.

引用本文的文献

1
Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential.心外膜脂肪组织在射血分数保留的心力衰竭中的作用:一种新出现的分子机制及治疗潜力
Obes Rev. 2025 Jul;26(7):e13912. doi: 10.1111/obr.13912. Epub 2025 Mar 1.
2
Critical Illness-Related Corticosteroid Insufficiency (CIRCI) Among Patients with COVID-19 at a Tertiary Hospital: Clinical Characteristics and Outcomes.COVID-19 患者在三级医院的危重病相关皮质激素不足(CIRCI):临床特征和结局。
J ASEAN Fed Endocr Soc. 2023;38(1):90-99. doi: 10.15605/jafes.038.01.02. Epub 2022 Dec 7.
3
A case of adrenal insufficiency during multisystem inflammatory syndrome in children.
一例儿童多系统炎症综合征期间的肾上腺功能不全病例。
Clin Pediatr Endocrinol. 2022;31(3):163-167. doi: 10.1297/cpe.2022-0011. Epub 2022 Mar 30.
4
The Relationship between COVID-19 and Hypothalamic-Pituitary-Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess-The CAPISCO International Expert Panel.新型冠状病毒肺炎与下丘脑-垂体-肾上腺轴的关系:从糖皮质激素不足到过度的大谱- CAPISCO 国际专家小组。
Int J Mol Sci. 2022 Jun 30;23(13):7326. doi: 10.3390/ijms23137326.
5
Unmasking of Addison's disease in COVID-19.新冠病毒病中艾迪生病的暴露
SAGE Open Med Case Rep. 2021 Jun 23;9:2050313X211027758. doi: 10.1177/2050313X211027758. eCollection 2021.
6
Adrenal Insufficiency in Coronavirus Disease 2019 (COVID-19)-Infected Patients without Preexisting Adrenal Diseases: A Systematic Literature Review.2019冠状病毒病(COVID-19)感染的无既往肾上腺疾病患者的肾上腺功能不全:一项系统文献综述
Int J Endocrinol. 2021 Sep 14;2021:2271514. doi: 10.1155/2021/2271514. eCollection 2021.
7
Central adrenal insufficiency and diabetes insipidus as potential endocrine manifestations of COVID-19 infection: a case report.新冠病毒感染潜在的内分泌表现:中枢性肾上腺功能不全和尿崩症:一例报告。
Pan Afr Med J. 2021 Feb 26;38:222. doi: 10.11604/pamj.2021.38.222.28243. eCollection 2021.
8
Adrenal insufficiency in coronavirus disease 2019: a case report.2019冠状病毒病中的肾上腺功能不全:一例报告
J Med Case Rep. 2020 Aug 24;14(1):134. doi: 10.1186/s13256-020-02461-2.
9
Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies.小儿多器官功能障碍综合征:有前景的治疗方法。
Pediatr Crit Care Med. 2017 Mar;18(3_suppl Suppl 1):S67-S82. doi: 10.1097/PCC.0000000000001053.
10
Mineralocorticoid deficiency in hemorrhagic shock.失血性休克中的盐皮质激素缺乏。
J Surg Res. 2013 Apr;180(2):232-7. doi: 10.1016/j.jss.2012.05.018. Epub 2012 May 25.